Skip to main content
Log in

N-desmethyldiazepam and amylobarbitone sodium as hypnotics in anxious patients. Plasma levels, clinical efficacy and residual effects

  • Original Investigations
  • Human Pharmacology
  • Published:
Psychopharmacologia Aims and scope Submit manuscript

Abstract

Drug plasma levels of N-desmethyldiazepam (10 and 20 mg/day given at night) and amylobarbitone sodium (200 mg/day given at night) were determined in 45 patients after 1 and 7 days of treatment together with estimates of hypnotic and residual effects. No relationships were found between clinical ratings of hypnotic effect and drug plasma levels, while significant correlations were observed between some performance tasks and drug plasma concentrations of amylobarbitone sodium, and of the higher dose of N-desmethyldiazepam.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  • Balasubramaniam, K., Lucas, S. B., Mawer, G. E., Simons, P. J.: The kinetics of amylobarbitone metabolism in healthy men and women. Brit. J. Pharmacol. 39, 564–572 (1970)

    Google Scholar 

  • Berlin, A., Siwers, B., Agurell, S., Hiort, A., Sjöqvist, F., Ström, S.: Determination of bioavailability of diazepam in various formulations from steady state plasma concentration data. Clin. Pharmacol. Ther. 13, 733–744 (1972)

    Google Scholar 

  • Bertagni, P., Marcucci, F., Mussini, E., Garattini, S.: Biliary excretion of conjugated hydroxyl benzodiazepines after administration of several benzodiazepines to rats, guinea pigs, and mice. J. pharm. Sci. 61, 965–966 (1972)

    Google Scholar 

  • Bond, A. J., Lader, M. H.: Residual effects of hypnotics. Psychopharmacologia (Berl.) 25, 117–132 (1972)

    Google Scholar 

  • Bond, A. J., Lader, M. H.: The residual effects of flurazepam. Psychopharmacologia (Berl.) 32, 223–235 (1973)

    Google Scholar 

  • Ehrnebo, M., Agurell, S., Boréus, L. O.: Gas Chromatographic determination of therapeutic levels of amobarbital and pentobarbital in plasma. Europ. J. clin. Pharmacol. 4, 191–195 (1972)

    Google Scholar 

  • Garattini, S., Marcucci, F., Morselli, P. L., Mussini, E.: The significance of measuring blood levels of benzodiazepines. In: Biological effects of drugs in relation to their plasma concentrations, Davies, D. S., and Prichard, B. N. C., eds., pp. 211–225. London: Macmillan 1973

    Google Scholar 

  • Hamilton, M.: The assessment of anxiety states by rating. Brit. J. med. Psychol. 32, 50–55 (1959)

    Google Scholar 

  • Kanto, J., Iisalo, E., Lehtinen, V., Salminen, J.: The concentrations of diazepam and its metabolites in the plasma after an acute and chronic administration. Psychopharmacologia (Berl.) 36, 123–131 (1974)

    Google Scholar 

  • Malpas, A., Rowan, A. J., Joyce, C. R. B., Scott, D. F.: Persistent behavioural and electroencephalographic changes after single doses of nitrazepam and amylobarbitone sodium. Brit. med. J. 1970 II, 762–764

    Google Scholar 

  • Marcucci, F., Mussini, E., Morselli, P. L., Garattini, S., Libretti, A., Zaccala, M.: Osservazioni sul metabolismo delle benzodiazepine nell'uomo. In: Atti II Riunione Nazionale Società Italiana di Neuropsicofarmacologia, Tirrenia, 14–16 giugno, 1969, Goldwurm, G. F., and Cassano, G. B., eds., pp. 63–70. Pisa: Pacini Mariotti 1969

    Google Scholar 

  • Morselli, P. L., Principi, N., Tognoni, G., Reali, E., Belvedere, G., Standen, S. M., Sereni, F.: Diazepam elimination in premature and full term infants, and children. J. Perinat. Med. 1, 133–141 (1973)

    Google Scholar 

  • Robinson, D. S., Sylwester, D. A.: Interaction of commonly prescribed drugs and warfarin. Ann. intern. Med. 72, 853–856 (1970)

    Google Scholar 

  • Sakalis, G., Curry, S. H., Mould, G. P., Lader, M. H.: Physiologic and clinical effects of chlorpromazine and their relationship to plasma level. Clin. Pharmacol. Ther. 13, 931–946 (1972)

    Google Scholar 

  • Schallek, W., Schlosser, W., Randall, L. O.: Recent developments in the pharmacology of the benzodiazepines. In: Advances in pharmacology and chemotherapy, Vol. 10, pp. 119–183. New York: Academic Press 1972

    Google Scholar 

  • Tansella, M.: Effetti collaterali dei farmaci inducenti il sonno. Acta neurol. (Napoli) 28, 481–497 (1973)

    Google Scholar 

  • Tansella, M., Zimmermann Tansella, Ch., Lader, M.: The residual effects of N-desmethyldiazepam in patients. Psychopharmacologia (Berl.) 38, 81–90 (1974)

    Google Scholar 

  • Van der Kleijn, E., Van Rossum, J. M., Muskens, E. T. J. M., Rijntjes, N. V. M.: Pharmacokinetics of diazepam in dogs, mice and humans. Acta pharmacol. (Kbh.) 29, Suppl. 3, 109–127 (1971)

    Google Scholar 

  • Viala, A., Cano, J. P., Dravet, C., Tassinari, C. A., Roger, J.: Blood levels of diazepam (Valium) and N-desmethyldiazepam in the epileptic child. Psychiat. Neurol. Neurochir. (Amst.) 74, 153–158 (1971)

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Tansella, M., Siciliani, O., Burti, L. et al. N-desmethyldiazepam and amylobarbitone sodium as hypnotics in anxious patients. Plasma levels, clinical efficacy and residual effects. Psychopharmacologia 41, 81–85 (1975). https://doi.org/10.1007/BF00421061

Download citation

  • Received:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00421061

Key words

Navigation